{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:26:20Z","timestamp":1792632380731,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113802","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:19:32Z","timestamp":1734517172000},"page":"113802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Membrane palmitoylated protein MPP1 inhibits immune escape by regulating the USP12\/ CCL5 axis in urothelial carcinoma"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3589-2507","authenticated-orcid":false,"given":"Qikai","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-6641","authenticated-orcid":false,"given":"Xiaojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113802_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2024.113802_b0010","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2024.113802_b0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.eururo.2020.02.028","article-title":"Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer","volume":"77","author":"Necchi","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.intimp.2024.113802_b0020","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0140-6736(17)33297-X","article-title":"Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial","volume":"391","author":"Powles","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113802_b0025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1470-2045(17)30065-7","article-title":"Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial","volume":"18","author":"Sharma","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2024.113802_b0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/dneu.20949","article-title":"Role of the MAGUK protein family in synapse formation and function","volume":"72","author":"Oliva","year":"2012","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.intimp.2024.113802_b0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrn.2016.18","article-title":"Mechanistic basis of MAGUK-organized complexes in synaptic development and signalling","volume":"17","author":"Zhu","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2024.113802_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25214954","article-title":"Not Just Another Scaffolding Protein Family: The Multifaceted MPPs","volume":"25","author":"Chytla","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.113802_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/genes14101942","article-title":"Recent Progress on Genetically Modified Animal Models for Membrane Skeletal Proteins: The 4.1 and MPP Families","volume":"14","author":"Terada","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.intimp.2024.113802_b0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3181\/0809-RM-275","article-title":"Identification of erythrocyte p55\/MPP1 as a binding partner of NF2 tumor suppressor protein\/Merlin","volume":"234","author":"Seo","year":"2009","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.intimp.2024.113802_b0055","doi-asserted-by":"crossref","first-page":"1265098","DOI":"10.3389\/fimmu.2023.1265098","article-title":"Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113802_b0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41420-024-01943-2","article-title":"USP12 facilitates gastric cancer progression via stabilizing YAP","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.intimp.2024.113802_b0065","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41388-021-02167-9","article-title":"Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1","volume":"41","author":"Li","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.113802_b0070","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/imm.13552","article-title":"USP12 positively regulates M-MDSC function to inhibit antitumour immunity through deubiquitinating and stabilizing p65","volume":"167","author":"Zhan","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2024.113802_b0075","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1038\/s41467-021-25032-5","article-title":"USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.113802_b0080","doi-asserted-by":"crossref","first-page":"e1011480","DOI":"10.1371\/journal.ppat.1011480","article-title":"USP12 promotes antiviral responses by deubiquitinating and stabilizing IFI16","volume":"19","author":"Fu","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2024.113802_b0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s12967-023-04540-6","article-title":"Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms","volume":"21","author":"Niu","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2024.113802_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006808","article-title":"Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression","volume":"11","author":"Xu","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2024.113802_b0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.113802_b0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eururo.2023.03.030","article-title":"Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial","volume":"84","author":"Grivas","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.intimp.2024.113802_b0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113802_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1173848","article-title":"Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma","volume":"14","author":"Cheng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113802_b0115","doi-asserted-by":"crossref","first-page":"642","DOI":"10.21037\/tau-23-166","article-title":"MPP7 is a potential prognostic marker and is associated with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a bioinformatics analysis based on the TCGA database","volume":"12","author":"Cheng","year":"2023","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.intimp.2024.113802_b0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adp7302","article-title":"Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity","volume":"9","author":"Zhang","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2024.113802_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114962","article-title":"ZDHHC3-mediated SCAP S-acylation promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma","volume":"43","author":"Wu","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2024.113802_b0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007939","article-title":"CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value","volume":"12","author":"Battaglin","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2024.113802_b0135","doi-asserted-by":"crossref","DOI":"10.1097\/CJI.0000000000000516","article-title":"Anti-VEGFR2-Interferon alpha Promotes the Infiltration of CD8+ T Cells in Colorectal Cancer by Upregulating the Expression of CCL5","author":"Huang","year":"2024","journal-title":"J. Immunother."},{"key":"10.1016\/j.intimp.2024.113802_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216892","article-title":"Anlotinib enhanced CD8(+) T cell infiltration via induction of CCL5 improves the efficacy of PD-1\/PD-L1 blockade therapy in lung cancer","volume":"591","author":"Luo","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2024.113802_b0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41420-024-01997-2","article-title":"NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53\/IRF1\/type I interferon signaling axis","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.intimp.2024.113802_b0150","doi-asserted-by":"crossref","first-page":"eadj2570","DOI":"10.1126\/sciadv.adj2570","article-title":"A dynamic ubiquitination balance of cell proliferation and endoreduplication regulators determines plant organ size","volume":"10","author":"Chen","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2024.113802_b0155","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1158\/0008-5472.CAN-22-3739","article-title":"The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-kappaB Regulator","volume":"83","author":"Gulei","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2024.113802_b0160","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1038\/s41418-021-00787-y","article-title":"USP12 promotes CD4(+) T cell responses through deubiquitinating and stabilizing BCL10","volume":"28","author":"Fu","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2024.113802_b0165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.fsi.2022.01.011","article-title":"Grouper USP12 exerts antiviral activity against nodavirus infection","volume":"121","author":"Zhang","year":"2022","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.intimp.2024.113802_b0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2024.113802_b0175","doi-asserted-by":"crossref","first-page":"E705","DOI":"10.1073\/pnas.1521763113","article-title":"Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling","volume":"113","author":"Jahan","year":"2016","journal-title":"PNAS"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:48:05Z","timestamp":1736614085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924023245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":35,"alternative-id":["S1567576924023245"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113802","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membrane palmitoylated protein MPP1 inhibits immune escape by regulating the USP12\/ CCL5 axis in urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113802"}}